电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CCR2 (Plozalizumab Biosimilar) 抗体

Research Grade 适用: 人 ELISA 宿主: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
产品编号 ABIN7488078
发货至: 中国
  • 抗原 See all CCR2 (Plozalizumab Biosimilar) products
    CCR2 (Plozalizumab Biosimilar)
    抗体类型
    Recombinant Antibody
    适用
    宿主
    • 1
    Mammalian Cells
    Expression System
    Mammalian cells
    克隆类型
    • 1
    单克隆
    标记
    • 1
    This CCR2 (Plozalizumab Biosimilar) antibody is un-conjugated
    应用范围
    ELISA
    原理
    Plozalizumab Biosimilar - Anti-CCR2, CD192 mAb
    产品特性
    Antibody Type: IgG1-kappa
    纯化方法
    Recombinant antibody expressed in mammalien cells and purified.
    质量等级
    Research Grade
    亚型
    IgG1 kappa
  • 限制
    仅限研究用
  • 缓冲液
    PBS pH 7.5
    储存条件
    -80 °C
    储存方法
    store at -80°C
  • 抗原
    CCR2 (Plozalizumab Biosimilar)
    Abstract
    CCR2 (Plozalizumab Biosimilar) 产品
    物质类
    Biosimilar
    背景
    MLN-1202,anti-CCR2,hu1D9
    Plozalizumab is a humanized monoclonal antibody that targets CCR2 chemokine receptors found on the surface of white blood cells such as macrophages and monocytes. Plozalizumab has been investigated to treat Atherosclerosis. CCR2 is supposed to play an important role in the trafficking of monocytes and macrophages to sites of inflammation.
    CAS-编号
    1610761-46-0
You are here:
客服